Skip to content

Source filing unavailable

Q1 2011 · —
Revenue$50.88M±0.0% vs Q1 2010−39.1% vs Q4 2010
Net Income$21.83M±0.0% vs Q1 2010−41.8% vs Q4 2010
EPS Diluted$0.48±0.0% vs Q1 2010−39.2% vs Q4 2010
Gross Profit$47,094,000±0.0%
Operating Income$22,604,000—
Operating Cash Flow$24,448,000—
Free Cash Flowderived$24,382,000—
Margins · derived
Gross margin92.6%±0.0 pt vs Q1 2010
Operating margin44.4%
Net margin42.9%±0.0 pt vs Q1 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2011Q1 2010
Revenue$50.88M$50.88M
Net Income$21.83M$21.83M
EPS Diluted$0.48$0.48

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR